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Dear Editor,
Renal cell carcinoma is the third most common urogenital neo-
plasia (1). The lung and bone tissues represent the most frequent
metastatic sites of renal cell carcinoma (2).Metastases in the stom-
ach are rare and have been essentially described during autopsies
(3). In this paper, we present a case of large metastatic gastric
tumor whose origin was a renal cell carcinoma treated years ago.
Case report
A 56 year old woman was diagnosed with stage one renal ade-
nocarcinoma 6 years ago. She was treated with right radical
nephrectomy and adjuvant chemotherapy. Three years later was
diagnosed and treated of brain metastasis located in the frontal
lobe, as well as in lung. A year ago, she came to our hospital for
upper gastrointestinal bleeding. She presented acceptable gener-
al condition and nutritional, blood pressure 120/70 mmHg and
normal cardio-respiratory auscultation. The abdomen was soft,
non-tender, and no masses or organ enlargements. The analyti-
cal study revealed 6.3 g/dl hemoglobin. A thoracic abdominal
TAC showed a large mass in the body and antrum stomach of
11 cm diameter without invasion adjacent structures. An upper
gastrointestinal endoscopy revealed a large neoplasm from body
to gastric antrum with mamelonated aspect. The patient under-
went subtotal gastrectomy. The postoperative course was unevent-
ful. The pathology and immunohistochemical study showed me-
tastasis of kidney carcinoma (Fig. 1).
Discussion
Metastatic gastric cancer is uncommon. The most frequent
location sites of cancer cells are in the body and gastric fundus,
and single tumors predominate against multiple. Although gen-
erally gastric metastases account for 0.2-0.7% of stomach tumors,
the metastatic tumor from carcinoma renal cells is extremely rare
(3) and is an event late. The gastric metastases from renal cell
carcinoma are diagnosed years after the primary tumor (4). The
histological diagnoses require immunohistochemical analysis for
differential diagnostic. We studied AE1/AE3 and vimentin mark-
ers, and the most recent CD10 and renal cell carcinoma mark-
ers (RCC-Ma). CD10 is a cell surface enzyme expressed in sev-
eral types of normal cells including the brush border of renal
tubular epithelial cells. Positivity for this marker is seen in more
than 90% of renal clear carcinomas (5). RCC-Ma is a monoclonal
antibody against a normal renal proximal tubule antigen. RCC-
Ma expression is relatively specific for primary clear cell in renal
carcinoma (6). In our case, the markers confirmed the diagnosis
of renal carcinoma. The classic vimentin and AE1/AE3 mark-
ers were strongly positive, while CD10 and RCC-Ma showed
moderately and weakly positive staining, respectively. The treat-
ment of gastric metastases is controversial. The patients have
poor prognosis with frequent extragastric metastases, and the
treatment is endoscopic therapy and arterial embolization (7,8).
The absence of evidence for other metastases and the presence
of large tumor did not support the consideration of therapeutic
endoscopy. By contrast, subtotal gastrectomy allowed acceptable
clinical and histological outcome. In summary, although the gas-
tric metastasis of renal carcinoma is rare and occurs late in life,
should be investigated systematically during management of
these patients.
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Fig. 1. A. Hematoxylin-eosin staining of the gastric mucosa which is preserved (left) and immediately below the neoplastic proliferation (4x). B. Immu-
nohistochemical studies of vimentin showing strong and diffusely positive staining (20x).
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